Published in Cancer Weekly, December 30th, 2003
In another chemotherapy-related study released December 5, 2003, the drug docetaxel - widely used for late-stage breast cancer since the mid-1990s - was found to be dramatically better at battling a common early-stage form of the disease than fluorouracil, long a standard treatment.
Research by the Breast Cancer International Research Group determined that 5 years after initial treatment,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.